Cargando…

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study

BACKGROUND: The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortner, Renée T, Schock, Helena, Jung, Seungyoun, Allen, Naomi E, Arslan, Alan A, Brinton, Louise A, Egleston, Brian L, Falk, Roni T, Gunter, Marc J, Helzlsouer, Kathy J, Idahl, Annika, Johnson, Theron S, Kaaks, Rudolf, Krogh, Vittorio, Lundin, Eva, Merritt, Melissa A, Navarro, Carmen, Onland-Moret, N Charlotte, Palli, Domenico, Shu, Xiao-Ou, Sluss, Patrick M, Staats, Paul N, Trichopoulou, Antonia, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Dorgan, Joanne F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672934/ https://www.ncbi.nlm.nih.gov/pubmed/28873086 http://dx.doi.org/10.1038/bjc.2017.299

Ejemplares similares

Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study
por: Schock, Helena, et al.
Publicado: (2016)

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case–control study in the Northern Sweden Maternity Cohort
por: Fortner, Renée T., et al.
Publicado: (2017)

Prospective Case–Control Study of Serum Müllerian Inhibiting Substance and Breast Cancer Risk
por: Dorgan, Joanne F., et al.
Publicado: (2009)

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
por: Clendenen, Tess V., et al.
Publicado: (2019)

Reliability of follicle-stimulating hormone measurements in serum
por: Arslan, Alan A, et al.
Publicado: (2003)

Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
por: Ose, J, et al.
Publicado: (2015)

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2011)

Temporal reliability of cytokines and growth factors in EDTA plasma
por: Clendenen, Tess V, et al.
Publicado: (2010)

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort
por: Fortner, Renée T., et al.
Publicado: (2017)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study
por: Li, K, et al.
Publicado: (2015)

Anti-Müllerian hormone levels and risk of type 2 diabetes in women
por: Verdiesen, Renée M. G., et al.
Publicado: (2020)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
por: Li, Kuanrong, et al.
Publicado: (2018)

Development and validation of circulating CA125 prediction models in postmenopausal women
por: Sasamoto, Naoko, et al.
Publicado: (2019)

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study
por: Tikk, Kaja, et al.
Publicado: (2015)

Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women’s Health Study for breast cancer
por: Lee, Myeonggyun, et al.
Publicado: (2023)

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

Premenopausal serum androgens and breast cancer risk: a nested case-control study
por: Zeleniuch-Jacquotte, Anne, et al.
Publicado: (2012)

Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study
por: Falk, Roni T, et al.
Publicado: (2013)

Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort
por: Le Cornet, Charlotte, et al.
Publicado: (2020)

Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort
por: Decker, Nina Sophia, et al.
Publicado: (2023)

Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study
por: Bešević, Jelena, et al.
Publicado: (2015)

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort
por: Fortner, Renée T., et al.
Publicado: (2017)

Adolescent endogenous sex hormones and breast density in early adulthood
por: Jung, Seungyoun, et al.
Publicado: (2015)

Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer
por: Mukama, Trasias, et al.
Publicado: (2022)

Aspirin and lung cancer in women
por: Akhmedkhanov, A, et al.
Publicado: (2002)

Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer
por: Onland-Moret, N C, et al.
Publicado: (2003)

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort
por: Sarink, Danja, et al.
Publicado: (2018)

Urinary endogenous sex hormone levels in postmenopausal women after caloric restriction in young adulthood
por: Elias, S G, et al.
Publicado: (2004)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk
por: Dorgan, Joanne F, et al.
Publicado: (2010)

Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors()()
por: Jonsson, Sarah, et al.
Publicado: (2018)

Chlamydia trachomatis and Anti-MUC1 Serology and Subsequent Risk of High-Grade Serous Ovarian Cancer: A Population-Based Case–Control Study in Northern Sweden
por: Jonsson, Sarah, et al.
Publicado: (2019)

The evolution of Müllerian mimicry
por: Sherratt, Thomas N.
Publicado: (2008)

Association between Use of Nutrition Labels and Risk of Chronic Kidney Disease: The Korean National Health and Nutrition Examination Survey (KNHANES) 2008–2019
por: Kim, Jonghee, et al.
Publicado: (2022)

Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors
por: Heidarpour, Mitra, et al.
Publicado: (2014)

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)

Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women
por: Verdiesen, Renée MG, et al.
Publicado: (2020)

Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
por: Obón-Santacana, M, et al.
Publicado: (2014)

Circulating oxysterols and prognosis among women with a breast cancer diagnosis: results from the MARIE patient cohort
por: Decker, Nina Sophia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8tg6mrnnnrbd5qpusjp7jtpfe